Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent Irregular Pigmented Macule on a Young Woman's Nose: Answer.

The American Journal of dermatopathology·2026
Same author

Recurrent Irregular Pigmented Macule on a Young Woman's Nose: Challenge.

The American Journal of dermatopathology·2026
Same author

Trends in Utilization of Mohs Micrographic Surgery for Malignant Adnexal Tumors of the Skin in the United States.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Quality of Information in Dermatologic Surgery Referrals: A Prospective Observational Cohort Study.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Frozen Sections in Clinic as a Real-Time Diagnostic Adjunct for Urgent Dermatologic Cases.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025
Same author

Nail Cutter as a Tool to Remove Necrotic Bone and Stimulate Granulation Tissue on Exposed Scalp Bone.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025
Same journal

Exosomes in Dermatology.

Skin therapy letter·2026
Same journal

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Skin therapy letter·2026
Same journal

Erratum to: Deuruxolitinib for Alopecia Areata.

Skin therapy letter·2026
Same journal

Advances in the Management of Hyperhidrosis.

Skin therapy letter·2026
Same journal

Topical Ruxolitinib for the Treatment of Hidradenitis Suppurativa.

Skin therapy letter·2026
Same journal

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Skin therapy letter·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Pediatric psoriasis.

Angie L Busch1, Jennifer M Landau, Megan N Moody

  • 1DermSurgery Associates, Houston, TX, USA.

Skin Therapy Letter
|February 24, 2012
PubMed
Summary
This summary is machine-generated.

Pediatric psoriasis, including plaque and guttate types, involves genetics and triggers. Treatment focuses on topical therapies, systemic agents for severe cases, and supportive care for children.

More Related Videos

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Related Experiment Videos

Last Updated: May 24, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Area of Science:

  • Pediatric Dermatology
  • Autoimmune Diseases
  • Genetics and Immunology

Background:

  • Psoriasis presents in various forms in children, with plaque and guttate being most common.
  • The autoimmune condition arises from a combination of genetic predisposition and environmental factors.
  • Identifying and removing triggers is crucial alongside symptom management.

Purpose of the Study:

  • To outline the common variants of pediatric psoriasis.
  • To discuss the etiological factors contributing to childhood psoriasis.
  • To present current therapeutic strategies for managing psoriasis in children.

Main Methods:

  • Review of common pediatric psoriasis types (plaque, guttate, diaper rash, pustular, erythrodermic).
  • Discussion of genetic and environmental influences on disease development.
  • Analysis of treatment approaches, including topical and systemic medications.

Main Results:

  • Plaque, guttate, and psoriatic diaper rash are the most frequent pediatric psoriasis forms.
  • Genetic susceptibility and environmental triggers are key contributors.
  • Topical treatments are primary, with systemic agents reserved for severe presentations.

Conclusions:

  • Effective pediatric psoriasis management requires a comprehensive approach.
  • Treatment plans should integrate symptom relief, trigger identification, and patient education.
  • Supportive care is an essential component of managing childhood psoriasis.